| Prabhsimranjot Singh, MD | |
|
450 Brookline Ave, Boston, MA 02215-5418 | |
| (617) 582-7956 | |
| Not Available |
| Full Name | Prabhsimranjot Singh |
|---|---|
| Gender | Male |
| Speciality | Hematology/oncology |
| Experience | 15 Years |
| Location | 450 Brookline Ave, Boston, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003106220 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 271233 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| South Shore Visiting Nurse Association | Rockland, MA | Home health agency |
| Nvna And Hospice | Norwell, MA | Hospice |
| Old Colony Hospice, Inc | W bridgewater, MA | Hospice |
| South Shore Hospital | South weymouth, MA | Hospital |
| Brigham And Women's Hospital | Boston, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dana-farber Cancer Institute, Inc. | 9133038904 | 538 |
News Archive
A malignancy-risk gene signature developed for breast cancer has been found to have predictive and prognostic value for patients with early stage non-small cell lung cancer. The advancement was made by researchers at Moffitt Cancer Center in Tampa, Fla., who published their study results in a recent issue of the Journal of the National Cancer Institute.
It's one of the first questions asked by many newly-diagnosed cancer patients-"What are my chances of beating this?" Often there is no clear answer, with survival rates differing widely depending on the cancer stage and available treatment options.
Breast augmentation is the most frequent type of plastic surgery done in the UK and - after nose reshaping and liposuction - it is the third most common cosmetic procedure in the USA.
For the first time, researchers have shown that a combination of perfluorinated substances in the mother significantly inhibits child growth.
A.D.A.M., Inc., a leading provider of consumer health information, benefits technology solutions and online education resources, today announced the release of A.D.A.M. Inside Out Health and Wellness—the newest module of its online resources for K-12 learners. This recent addition to the A.D.A.M. Education suite of products is designed to assist educators in teaching nutrition, the significance of healthy eating, and the importance of incorporating 60 minutes of physical activities into students' daily routines.
› Verified 9 days ago
| Entity Name | Dana-farber Cancer Institute, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346433257 PECOS PAC ID: 9133038904 Enrollment ID: O20040223000142 |
News Archive
A malignancy-risk gene signature developed for breast cancer has been found to have predictive and prognostic value for patients with early stage non-small cell lung cancer. The advancement was made by researchers at Moffitt Cancer Center in Tampa, Fla., who published their study results in a recent issue of the Journal of the National Cancer Institute.
It's one of the first questions asked by many newly-diagnosed cancer patients-"What are my chances of beating this?" Often there is no clear answer, with survival rates differing widely depending on the cancer stage and available treatment options.
Breast augmentation is the most frequent type of plastic surgery done in the UK and - after nose reshaping and liposuction - it is the third most common cosmetic procedure in the USA.
For the first time, researchers have shown that a combination of perfluorinated substances in the mother significantly inhibits child growth.
A.D.A.M., Inc., a leading provider of consumer health information, benefits technology solutions and online education resources, today announced the release of A.D.A.M. Inside Out Health and Wellness—the newest module of its online resources for K-12 learners. This recent addition to the A.D.A.M. Education suite of products is designed to assist educators in teaching nutrition, the significance of healthy eating, and the importance of incorporating 60 minutes of physical activities into students' daily routines.
› Verified 9 days ago
| Entity Name | Dana-farber Cancer Institute, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851333686 PECOS PAC ID: 9133038904 Enrollment ID: O20040223000228 |
News Archive
A malignancy-risk gene signature developed for breast cancer has been found to have predictive and prognostic value for patients with early stage non-small cell lung cancer. The advancement was made by researchers at Moffitt Cancer Center in Tampa, Fla., who published their study results in a recent issue of the Journal of the National Cancer Institute.
It's one of the first questions asked by many newly-diagnosed cancer patients-"What are my chances of beating this?" Often there is no clear answer, with survival rates differing widely depending on the cancer stage and available treatment options.
Breast augmentation is the most frequent type of plastic surgery done in the UK and - after nose reshaping and liposuction - it is the third most common cosmetic procedure in the USA.
For the first time, researchers have shown that a combination of perfluorinated substances in the mother significantly inhibits child growth.
A.D.A.M., Inc., a leading provider of consumer health information, benefits technology solutions and online education resources, today announced the release of A.D.A.M. Inside Out Health and Wellness—the newest module of its online resources for K-12 learners. This recent addition to the A.D.A.M. Education suite of products is designed to assist educators in teaching nutrition, the significance of healthy eating, and the importance of incorporating 60 minutes of physical activities into students' daily routines.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Prabhsimranjot Singh, MD 450 Brookline Ave, Boston, MA 02215-5418 Ph: (617) 582-7956 | Prabhsimranjot Singh, MD 450 Brookline Ave, Boston, MA 02215-5418 Ph: (617) 582-7956 |
News Archive
A malignancy-risk gene signature developed for breast cancer has been found to have predictive and prognostic value for patients with early stage non-small cell lung cancer. The advancement was made by researchers at Moffitt Cancer Center in Tampa, Fla., who published their study results in a recent issue of the Journal of the National Cancer Institute.
It's one of the first questions asked by many newly-diagnosed cancer patients-"What are my chances of beating this?" Often there is no clear answer, with survival rates differing widely depending on the cancer stage and available treatment options.
Breast augmentation is the most frequent type of plastic surgery done in the UK and - after nose reshaping and liposuction - it is the third most common cosmetic procedure in the USA.
For the first time, researchers have shown that a combination of perfluorinated substances in the mother significantly inhibits child growth.
A.D.A.M., Inc., a leading provider of consumer health information, benefits technology solutions and online education resources, today announced the release of A.D.A.M. Inside Out Health and Wellness—the newest module of its online resources for K-12 learners. This recent addition to the A.D.A.M. Education suite of products is designed to assist educators in teaching nutrition, the significance of healthy eating, and the importance of incorporating 60 minutes of physical activities into students' daily routines.
› Verified 9 days ago
Kaitlyn My-tu Lam, MBBS Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114 Phone: 617-724-7738 | |
Kui Toh Gerard Leong, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 55 Fruit Street, Massachusetts General Hospital, Boston, MA 02114 Phone: 617-726-8862 | |
Ruma Rajbhandari, Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 75 Francis St, Boston, MA 02115 Phone: 617-525-6841 | |
Alaka Ray, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114 Phone: 617-726-2066 | |
Meghan E Sise, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114 Phone: 617-726-2862 | |
Aaron Dickstein, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 800 Washington St, Box 233, Boston, MA 02111 Phone: 617-636-5883 Fax: 617-636-9292 | |
Dr. Felicia Elizabeth Patch, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 801 Massachusetts Ave, Crosstown 2, Boston, MA 02118 Phone: 617-414-4376 Fax: 617-414-4676 |